hVIVO PLC has named Angela Hildreth as its new chief financial officer and board director, effective November 18, succeeding interim CFO Richard Cotton. The appointment supports hVIVO's strategy for sustainable, profitable growth and long-term shareholder value, leveraging opportunities across its service lines and expanded therapeutic offerings. Hildreth brings over 15 years of financial leadership in healthcare, including experience guiding Futura Medical through commercialization and regulatory approvals in Europe and the US. This leadership change aims to strengthen hVIVO's financial and operational capabilities as it advances its clinical development services.
The story about hVIVO's new finance chief comes with a snapshot of the health sector on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 12, 2026 15:02 WIB: Among 128 priced health-sector US stocks, 60 rose and 29 fell today. Notable movers include TECH (BIO-TECHNE Corp) at USD 73.44 with a 1-day change of +1.35% and a typical hold time on Pluang of 64 days, EXEL (Exelixis Inc. Common Stock) at USD 60.57 with +1.19%, and AMLX (Amylx Pharmaceuticals Inc) at USD 28.47 with +1.17%.
STERIS plc announced it will acquire Xodus Medical, a specialty surgical products company, for $2.1 billion, with the deal expected to close by December 31, 2026. The acquisition will expand STERIS's healthcare consumables portfolio, particularly in ...
Nano Labs Ltd announced its 2026 Annual General Meeting on November 24, 2026, in Hangzhou, China. The meeting will seek shareholder approval for a share consolidation (10-to-1), re-designation of shares into Class A and B, and a conditional share sub...
Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the com...
The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...
Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patien...
